Medication Guide - 11/30/2020

Medication guides are FDA- approved documents that address issues that are specific to particular drugs, and can help patients avoid serious adverse events (side effects). This database does not include Medication Guides for FDA-approved allergenic or cellular/tissue products (see  FDA Online Label Repository  or DailyMed  for these Medication Guides).  More Drug Name Active Ingredient Form;Route Appl. No. Company Date Aciphex Rabeprazole Sodium TABLET, DELAYED RELEASE;ORAL 020973 EISAI INC 11/27/2020 Aciphex Sprinkle Rabeprazole Sodium CAPSULE, DELAYED RELEASE;ORAL 204736 AYTU 11/27/2020 Dexilant Dexlansoprazole CAPSULE, DELAYED RELEASE;ORAL 022287 TAKEDA PHARMS USA 11/27/2020 Esomeprazole Strontium Esomeprazole Strontium CAPSULE, DELAYED RELEASE;ORAL 202342 BELCHER 11/27/2020 Nexium Esomeprazole Magnesium CAPSULE, DELAYED REL PELLETS;ORAL 021153 ASTRAZENECA PHARMS 11/27/2020 Prevacid Lansoprazole TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL 021428 TAKEDA PHARMS USA 11/27/2020 Prilosec Omeprazole Magnesium FOR SUSPENSION, DELAYED RELEASE;ORAL 022056 COVIS PHARMA BV 11/27/2020 Protonix Pantoprazole Sodium FOR SUSPENSION, DELAYED RELEASE;ORAL 022020 WYETH PHARMS 11/27/2020 Vimovo Esomeprazole Magnesium; Naproxen TABLET, DELAYED RELEASE;ORAL 022511 HORIZON 11/27/2020 Yosprala Aspirin; Omeprazole TABLET, DELAYED RELEASE;ORAL 205103 GENUS LIFESCIENCES 11/27/2020 Zegerid Omeprazole; Sodium Bicarbonate CAPSULE;ORAL 021849 SALIX 11/27/2020 Jynarque Tolvaptan TABLET;ORAL 204441 OTSUKA PHARM CO LTD 11/25/2020 Idhifa Enasidenib Mesylate TABLET;ORAL 209606 CELGENE CORP 11/24/2020 Ziagen Abacavir Sulfate TABLET;ORAL 020977 VIIV HLTHCARE 11/24/2020 Nplate Romiplostim INJECTABLE; SUBCUTANEOUS 125268 AMGEN 11/23/2020 Blenrep Belantamab Mafodotin-Blmf INJECTABLE;INTRAVENOUS 761158 GLAXOSMITHKLINE 11/20/2020 Palynziq Pegvaliase-Pqpz INJECTABLE;INJECTION 761079 BIOMARIN PHARM 11/20/2020 Pomalyst Pomalidomide CAPSULE;ORAL 204026 CELGENE 11/20/2020 Soliris Eculizumab INJECTABLE; IV (INFUSION) 125166 ALEXION PHARM 11/20/2020 Victoza Liraglutide Recombinant SOLUTION;SUBCUTANEOUS 022341 NOVO NORDISK INC 11/20/2020   Manage Subscriptions  |  Unsubscribe All  |  Help This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA